Phase II study of nab-paclitaxel for pretreated NSCLC
Phase 2
- Conditions
- on-small cell lung cancer
- Registration Number
- JPRN-UMIN000014357
- Lead Sponsor
- Kitasato university hospital, division of respiratory medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
Hypersensitivity for drugs and albumin. patient with grade 2 of peripheral neuropathy. Patient with severe infection. Patient with Patient with SVC. Patient with uncontroled diabetes mellitus, angina,heart disease and gastrointestinal ulceration.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Response rate
- Secondary Outcome Measures
Name Time Method PFS,OS, safty